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152a Sunday, February 3, 2013oxygen species and lipid peroxidation in the testis with concomitant decrease
in sperm count and motility in a dose dependent manner. Activities of
antioxidant enzymes catalase, superoxide dismutase and levels of reduced
glutathione were found to be decreased in a dose dependent manner. Also,
the levels of oxidized glutathione were increased leading to a shift in redox
ratio. The testicular histomorphology was also altered dose dependently.
Germ cell kinetic study revealed significant loss of various germ cell popula-
tions with increasing dose of quercetin. Interestingly, there was a reduction
in germinal epithelium thickness concomitant with an increase in seminiferous
tubule lumen diameter. In conclusion, the deleterious effects of quercetin on
germ cells could be attributed to its pro-oxidant ability which might affect
the sertoli cell functions.
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Cilia function is critical to human health. We developed quantitative methods
to describe waveform, propulsive force, and net work of cilia on multi-ciliated
human tracheal epithelial cells (HTEC).
Lung tracheobronchial epithelial cells were isolated from healthy donor sub-
jects for culture and differentiated using growth factor-enriched medium and
air-liquid interface conditions to yield multi-ciliated cells. Detached cells in
20 mL of culture medium at room temperature were sandwiched between a glass
slide and coverslip and lateral views of beating cilia were acquired (Zeiss
Axiophot, 100X, oil immersion, DIC) for 2s at 100 fps (320x240 pixels,
15.07 pixels/mm). Waveforms were analyzed in N=21 cilia from 3 subjects.
In each video frame, 30 points evenly distributed from the base to the tip of
the cilium were fitted to a 4th-order polynomial curve. The resulting parameter
sets were Fourier-transformed and filtered temporally to obtain a space-time
surface representing a typical beat. Local velocity vectors and curvature
were computed by differentiation of this surface, and local fluid forces on
the cilium were estimated using resistive force theory: fN = CNvN and fT =
CTvT (CNz1.5x10
3 pN-s/mm; CT z0.7x10
3 pN-s/mm). Power was calcu-
lated from the product f$v. Beat frequency, curvature, and shear amplitude
were also computed.
Waveforms of active cilia were asymmetric with distinct power and recovery
strokes. The average propulsive force and work for active HTEC cilia were:
Fprop=3.7354.42pN, W=1.6351.84aJ. We also identified apparently passive
cilia with nearly symmetric waveforms and little propulsive effectiveness
(Fprop= 0.02 51.52 pN, W=0.3350.24aJ). Active cilia were longer
(6.48 50.66 vs 5.0950.73mm) and beat more rapidly (3.54 50.77Hz vs
2.6451.16Hz) than passive cilia. It is not clear whether passive cilia are imma-
ture or simply represent normal heterogeneity. These results provide baseline
data for future studies of motility defects.
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In this work the equilibrium shape and dynamics of a primary cilium under flow
are investigated using both theoretical modeling and experiment. The cilium is
modeled as an elastic beam that may undergo large deflection due to the hydro-
dynamic load. Equilibrium results show that the anchoring effects of the basal
body on the cilium axoneme behave as a nonlinear rotational spring. Details of
the rotational spring are elucidated by coupling the elastic beam with an elastic
shell. We further study the dynamics of cilium under shear flow with the cilium
base angle determined from the nonlinear rotational spring, and obtain good
agreement in cilium bending and relaxing dynamics when comparing between
modeling and experimental results. These results potentially shed light on the
physics underlying the mechanosensitive ion channel transport through the
ciliary membrane.
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Energetic efficiency of swimming has long been considered a non-issue in
microorganisms, but newer studies show that ciliates can use more than half
of their energy for propulsion. To estimate how close the ciliates are to the
theoretically optimal way of swimming we address the following problems:
i) we determine the optimal stroke of a cilium, ii) we determine the optimalbeating pattern of a ciliated surface and iii) we calculate the optimal shape
of a ciliated swimmer.
For a single cilium we define the efficiency in a scale-invariant way and show
that the optimal stroke consists of a working stroke with a stretched cilium and
a recovery stroke where the cilium bends and moves closer to the surface.
When optimizing an array of cilia we additionally show that metachronal
waves improve the efficiency and that the optimal efficiency is achieved for
antiplectic waves. The resulting beating patterns, as well as the optimal ciliary
density, show remarkable similarity with those observed in ciliated microor-
ganisms. In order to optimize the shape of the whole swimmer we use a simpli-
fied description where we replace the ciliated layer with a surface slip velocity.
Depending on the curvature we allow, the optimal swimmer has an elongated
shape, possibly with two protrusions along the symmetry axis. These optimal
shapes again resemble those of different ciliates.
If we combine the results of our optimization with experimental efficiency es-
timates we can show that Paramecium has a propulsion efficiency that is within
a factor of 2 of the theoretical optimum. This result suggests that ciliates have
evolved for efficient swimming at different scales.
[1] N. Osterman and A. Vilfan, Proc. Natl. Acad. Sci. USA 108, 15727-15732
(2011)
[2] A. Vilfan, Phys. Rev. Lett. 109, 128105 (2012)Cardiac Muscle I
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Understanding how cellular level mechanical properties change as failing
hearts remodel may help identify the protein modifications that produce con-
tractile dysfunction associated with this condition. We therefore procured
through wall left ventricular samples from patients undergoing heart trans-
plants at the University of Kentucky and from organ donors who did not
have heart failure. Multicellular chemically permeabilized preparations were
subsequently obtained from sub epicardial, midwall and sub endocardial re-
gions of these samples by mechanical homogenization and triton treatment.
The mechanical properties of the preparations were assessed by attaching
them between a force transducer and a motor and subjecting them to a standard
series of mechanical assays. There was a 30% decrease in maximum power
output (p-value = 0.01) and steady-state force (p-value=0.005) in patients
with end-stage heart failure (n=8, total of 72 preparations) as compared to sam-
ples from nonfailing organ donors (n=4, total of 36 preparations). The phos-
phorylation of two cardiac sarcomeric proteins- myosin binding protein-C
(cMyBP-C) and troponin-I (cTnI) which have been previously associated
with contractile dysfunction were investigated using phospho specific anti-
bodies. Western blot analysis of three major phosphorylated sites of cMyBP-
C, PSer273, PSer282 and PSer302 were not significantly different between
heart failure and non failing groups but cTnI phosphorylation at PSer22/23 de-
creased significantly in heart failure (p=0.01). This study suggests that the cel-
lular level mechanical dysfunction seen in heart failure may be in part due to
phosphorylation modifications.
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Sunday, February 3, 2013 153aPatients in heart failure are sometimes implanted with a left ventricular assist
device (LVAD) to bridge them to transplant. Clinical data shows that ~15%
of these patients recover pump function and can subsequently have their
LVAD removed. The goal of our study was to determine whether cellular level
maximal power output of the left ventricle improves after patients are fitted
with LVADs. Myocardial samples were obtained (1) from the left ventricle
apex of patients when they were implanted with a LVAD and (2) from the
left ventricle free wall when they subsequently received a heart transplant.
Non failing cardiac samples were also obtained from organ donors for compar-
ison. All samples were snap frozen in liquid nitrogen and stored in the vapor
phase of liquid nitrogen. Multicellular preparations were then obtained by
chemically permeabilizing the samples in 1% Triton solution after mechanical
homogenization. These preparations were connected between a force trans-
ducer and a motor and maximally activated in a saturating Ca2þ solution.
Once force had reached steady state, the preparations were allowed to shorten
against pre-set loads imposed using SLControl software. Maximum power out-
put was determined from the force-velocity curves. Preliminary results suggest
that LVAD treatment improved cellular level maximum power output and
isometric force. There was also a trend towards a lower maximum shortening
velocity post-LVAD. Further studies, will determine whether intrinsic ventric-
ular function is improved by LVAD implantation as well as the molecular
mechanisms that may mediate any observed responses.
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Omecamtiv mecarbil (OM), a small-molecule increases cardiac contractility by
directly activating cardiac myosin by accelerating phosphate (Pi) release (Ma-
lik et al., 2011). Here we analyzed the affect of OM on the mechanochemical
cycle and motility of human b-cardiac heavymeromyosin expressed in a adeno-
viral/C2C12 muscle cell based system, and purified porcine ventricular myosin
(PV-HMM). Double-mixing stopped-flow fluorescence and phosphate binding
protein (MDCC-PBP) were used to determine the maximum rate (kmax) of
phosphate release. Rates of 30s1 and 35s1 were obtained for human and
porcine cardiac HMM respectively. Addition of 20 mM OM resulted in a
2-fold increase in the maximal rate of actin activated Pi release to kmax =
70 s1 (AM-ADP-Pi _> AM-ADP þ Pi) for both human and porcine cardiac
HMM. The unloaded actin filament velocity measured in the in vitro motility
assay was 0.76 5 0.37 mm/sec for human b-cardiac HMM and 0.97 5 0.23
mm/sec for PV-HMM. OM has two effects on the motor activity: 1) The actin
filament velocity was significantly slower (~ 16 -fold at saturation); 2) the fil-
ament motion became more persistent with long periods of uninterrupted
movement. This suggests that OM recruits more crossbridges to participate
in the movement of the actin filaments resulting in higher forces per filament,
which overcomes the pinning defects that invariably trap actin filaments in nor-
mal motility assays. The increase in attached crossbridges/filament also slows
the filament velocity. The motility data are consistent with the kinetic analysis
indicating that OM accelerates Pi release without dramatically enhancing the
rate of the ATPase hydrolysis. This produces a higher duty ratio in which the
motor spends more of the ATPase cycle in tight binding states. Supported by
AHA-BGIA to EF and AHA-GI to DAW.
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After myocardial infarction, adjacent to the infarct there is a poorly contracting
non-ischemic border zone. The mechanism of border zone dysfunction is un-
clear. We found that border zone dysfunction does not involve myocardial
fibrosis, or a decreased content of either myofibrils or myosin, suggesting there
is a defect in the contractile mechanism. Goal: Determine the mechanism for
border zone dysfunction. Methods: We used sheep hearts 2 weeks after
apical infarction. Cardiac muscle strips were dissected from the border zone
adjacent to the infarct and from a zone remote from the infarct. Myofilament
contraction was assessed using in-vitro isometric and isotonic contractions of
demembranated cardiac muscle strips bathed in activating solutions. To assess
strongly bound cross-bridge formation, we measured muscle stiffness using
high frequency, low amplitude oscillations of muscle length in the absenceof ATP (in this rigor state, cross bridge formation should be maximal).
Results: In border zone myocardium, maximal force development (Fmax)
was reduced by 3152% (n=6, P<0.01) compared to Fmax of remote zone
myocardium (8551 mN/mm2). The stiffness in the rigor state was reduced
by 3456% (n=5, P<0.05) in border zone myocardium versus remote zone
myocardium, suggesting impaired cross bridge formation in the border zone.
There was no difference between border zone and remote zone myocardium
in the maximum velocity of muscle shortening (~0.35 muscle lengths/s),
or in the rate constant of force redevelopment (Ktr, ~2.5 s1) after briefly
mechanically disrupting cross bridges with a rapid perturbation of muscle
length. Conclusions: Impaired contraction of border zone myocardium
involves a reduction in cross bridge formation, without effects on cross bridge
kinetics. Preliminary studies suggest proteolytic cleavage of contractile pro-
teins may play a role.
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Heart failure is characterized by a decrease in cardiac contractility and is a lead-
ing cause of morbidity and mortality. Treatment with cardiac glycosides such
as digitalis increases cardiac contractility by elevating intracellular calcium
through inhibition of the sodium-potassium ATPase (NKA). However, the ther-
apeutic window for this class of drugs is narrow as high calcium levels lead to
increased SR load, calcium leak, and cardiac arrhythmias. Alternatively, the
endogenous inhibitor of NKA, phospholemman (PLM), is dynamically regu-
lated. We hypothesize that a superinhibitory mutant of PLM will increase the
contractility of cardiac myocytes. This effect will be inherently self-limiting
since inhibition of NKA is relieved by phosphorylation or elevated intracellular
sodium. Here we used a high-throughput screen of PLM mutants utilizing fluo-
rescence microscopy to simultaneously measure PLM-NKA and PLM-PLM
binding. By tagging NKA with CFP and PLM with YFP, we can measure
NKA-PLM binding with heterotransfer FRET (CFP to YFP) and oligomeriza-
tion of PLM with homotransfer FRET (YFP to YFP). We observed that several
mutants have a decreased affinity for oligomerization (PLM-PLM binding)
leading to an increased apparent affinity for NKA. Future plans include creating
and screening many more mutants and measuring the functional effect of PLM-
based superinhibitors in vitro and in vivo.
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Ventricular fibrillation is one of the leading causes of death in the world.
Current therapy is based on a high-energy electric shock, which indiscrimin-
ately excites every cell in the muscle and may cause severe side effects such
as tissue damage and intolerable pain. The complex spatio-temporal dynamics
of fibrillation, induced by multiple interacting spiral waves, makes the design of
robust low-energy control strategies a challenging scientific problem.
Low-energy electric field stimuli lead to the formation of wave emitting sites at
structural heterogeneities in the tissue, with a density adjustable through field
strength. By applying a sequence of electric-field pulses, Low-Energy Anti-
Fibrillation pacing (LEAP) uses these wave sources to non-invasively control
the tissue from multiple sites and terminate fibrillation by progressive synchro-
nization. We present experiments on canine dogs, investigating the application of
LEAP to atrial (in-vitro and in-vivo) and ventricular fibrillation (in-vitro) as well
as the wave source recruitment mechanism in quiescent tissue [1]. We show that
the observed wave source density is in agreement with theoretical predictions
based on the size distribution of the cardiovascular tree. These findings are sup-
ported and extended by theoretical investigations revealing a general curvature-
dependent sensitivity of anatomical features to electric-field stimulation [2].
LEAP results in an energy reduction of 80% for the termination of fibrillation
compared to conventional defibrillation. Further energy reduction might be pos-
sible in specific scenarios by making use of negative-curvature structures on the
endocardium such as trabecular, papillary and pectinate muscles.
References:
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